Texas 2019 86th Regular

Texas House Bill HB746 Introduced / Bill

Filed 01/11/2019

                    86R1575 KKR-F
 By: Rose H.B. No. 746


 A BILL TO BE ENTITLED
 AN ACT
 relating to the establishment by certain counties and hospital
 districts of disease control pilot programs to reduce the risk of
 certain infectious and communicable diseases; authorizing fees.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  The legislature finds that because drug abuse
 has been a tragedy for many Texas families, it is imperative for
 individuals addicted to drugs to receive education about and
 treatment for addiction. Cooperation with community-based and
 faith-based organizations creates a network of support for Texas
 families and the opportunity to intervene in drug addiction.
 Members of community-based and faith-based organizations have a
 strong desire to compassionately work to preserve lives and offer
 help to those stricken with disease and drug addiction.
 Allowing for the operation of disease control pilot programs
 will reduce the transmission of bloodborne diseases, including
 HIV/AIDS, hepatitis B, and hepatitis C, and provide clients with
 referrals to appropriate health and social services. A pilot
 program created under this Act may provide necessary access to
 primary health care, ensure safe and sterile disposal of used
 syringes and needles, and protect the public health. In addition,
 pilot program goals may include reduced rates of intravenous drug
 use and a reduced number of injuries to innocent victims, first
 responders, and law enforcement caused by needle sticks from
 improperly disposed needles. Additionally, it is the intent of the
 legislature for the pilot program to increase access to drug
 treatment centers, increase the likelihood of successful
 treatments for addiction, and protect the public health and safety.
 SECTION 2.  Section 531.0972, Government Code, is amended to
 read as follows:
 Sec. 531.0972.  PILOT PROGRAM TO PREVENT [THE] SPREAD OF
 CERTAIN INFECTIOUS AND [OR] COMMUNICABLE DISEASES. The commission
 may provide guidance to the counties and hospital districts in
 those counties that establish [local health authority of Bexar
 County in establishing] a pilot program under Subchapter K, Chapter
 81, Health and Safety Code, [funded by the county] to prevent the
 spread of HIV, hepatitis B, hepatitis C, and other infectious and
 communicable diseases.  The program may include a disease control
 program that provides for the anonymous exchange of used hypodermic
 needles and syringes.
 SECTION 3.  Chapter 81, Health and Safety Code, is amended by
 adding Subchapter K to read as follows:
 SUBCHAPTER K. PILOT PROGRAM TO REDUCE RISK OF CERTAIN INFECTIOUS
 AND COMMUNICABLE DISEASES
 Sec. 81.501.  APPLICABILITY OF SUBCHAPTER. This subchapter
 applies only to Bexar, Dallas, Harris, and Travis Counties and
 hospital districts in those counties.
 Sec. 81.502.  DISEASE CONTROL PILOT PROGRAM. (a) A county
 or hospital district may establish a disease control pilot program
 under this subchapter to prevent the spread of HIV, hepatitis B,
 hepatitis C, and other infectious and communicable diseases. The
 pilot program may include disease control outreach programs that:
 (1)  provide for the anonymous exchange of used
 hypodermic needles and syringes for an equal number of new
 hypodermic needles and syringes;
 (2)  offer education on the transmission and prevention
 of infectious and communicable diseases, including HIV, hepatitis
 B, and hepatitis C; and
 (3)  assist program participants in obtaining health
 care and other physical and mental health-related services,
 including substance abuse treatment services and bloodborne
 disease testing.
 (b)  A county or hospital district may register an
 organization to operate the disease control pilot program and
 distribute hypodermic needles and syringes to control the spread of
 certain bloodborne communicable diseases. The county or hospital
 district may charge a registration fee in an amount reasonable and
 necessary to cover the costs of registration oversight, including
 coordination with law enforcement personnel.
 (c)  A registered organization may charge a participant in
 the program a fee for each hypodermic needle or syringe used in the
 program not to exceed 150 percent of the actual cost to the
 organization of the hypodermic needle or syringe.
 (d)  A registered organization shall annually provide to the
 department and the county or hospital district with which the
 organization is registered information on:
 (1)  the effectiveness of the program;
 (2)  the program's impact on reducing the spread of
 infectious and communicable diseases, including HIV, hepatitis B,
 and hepatitis C; and
 (3)  the program's effect on injected drug use in the
 county or hospital district.
 Sec. 81.503.  DISTRIBUTION OF NEEDLES AND SYRINGES TO PILOT
 PROGRAM. A person licensed as a wholesale drug distributor or
 device distributor under Chapter 431 may distribute hypodermic
 needles and syringes to a disease control pilot program authorized
 by this subchapter.
 Sec. 81.504.  HANDLING OF NEEDLES AND SYRINGES. A
 registered organization:
 (1)  shall store hypodermic needles and syringes in a
 proper and secure manner and allow only authorized employees or
 volunteers of the organization's disease control pilot program to
 access the hypodermic needles and syringes;
 (2)  may include hypodermic needles and syringes in
 packaged safe kits made available to program clients through the
 program;
 (3)  may provide hypodermic needles and syringes and
 safe kits to program clients only through an authorized employee or
 volunteer of the program; and
 (4)  shall store and dispose of used hypodermic needles
 and syringes in accordance with applicable state laws and
 administrative rules governing the safe and proper disposal of
 medical waste.
 Sec. 81.505.  FUNDING. Except to the extent specifically
 prohibited by law, a registered organization operating a disease
 control pilot program may solicit or accept gifts, grants, or
 donations to fund a disease control pilot program under Section
 81.502(a).
 Sec. 81.506.  EXPIRATION.  This subchapter expires September
 1, 2029.
 SECTION 4.  Section 481.125, Health and Safety Code, is
 amended by adding Subsections (g), (h), and (i) to read as follows:
 (g)  Subsections (a) and (b) do not apply to a person who
 dispenses or delivers a hypodermic needle or syringe for a medical
 purpose. For the purposes of this subsection, "medical purpose"
 includes the exchange of a hypodermic needle or syringe for a used
 hypodermic needle or syringe in a disease control pilot program
 described by Subchapter K, Chapter 81.
 (h)  Subsections (a) and (b) do not apply to a person who
 manufactures hypodermic needles or syringes for delivery to a
 disease control pilot program described by Subchapter K, Chapter
 81.
 (i)  Subsections (a) and (b) do not apply to a person who is
 an employee, volunteer, duly authorized agent, or program client of
 a disease control pilot program described by Subchapter K, Chapter
 81, and uses, possesses, or delivers a hypodermic needle or syringe
 as part of the program.
 SECTION 5.  The change to Section 481.125, Health and Safety
 Code, made by this Act applies only to an offense committed on or
 after the effective date of this Act. An offense committed before
 the effective date of this Act is governed by the law in effect when
 the offense was committed, and the former law is continued in effect
 for that purpose. For purposes of this section, an offense is
 committed before the effective date of this Act if any element of
 the offense occurs before the effective date.
 SECTION 6.  This Act takes effect September 1, 2019.